Our Collaborative Approach to Supporting Ophthalmology Clinical Trials

Therapeutic Depth:CNS

Someone goes blind every five seconds, a child, every minute. A leading cause of blindness is glaucoma but half of the nearly 60 million people afflicted worldwide do not realize it because, often, there are no warning signs. Facts about blindness and eye health make clear the need for new ophthalmic treatments is acute.

At SynteractHCR, we are at the forefront of ophthalmology clinical trials. SynteractHCR ophthalmology expertise includes:

  • Cataracts
  • Corneal Opacity
  • Corneaplasty
  • Diabetic Macular Edema
  • Dry Eye Syndrome
  • Glaucoma
  • Intraocular Lens
  • Macular Degeneration
  • Macular Edema
  • Polypoidal Choroidal Vasculopathy
  • Post Vitrectomy Inflammation
  • Posterior Segment Diseases
  • Posterior Vitreous Detachment
  • Retinal Vein Occlusion
  • Vitreous Hemorrhage

Related Links

Well-rounded experience.

SynteractHCR has conducted
trials across all major
therapeutic areas and
we have contributed 
to more than 230
product approvals
since our
founding.
Learn More

Contact SynteractHCR

  • USA: +1 760 268 8200
  • Europe: +49 89 12 66 80 0
  • Contact Form...

Contact SynteractHCR

Tell us how to stay in touch with you:


Required Fields(*)
Cancel